Prognostic value of circulating tumor cells in patients with non-small cell lung cancer: a Meta-analysis

Prognostic value of circulating tumor cells in patients with non-small cell lung cancer: a Meta-analysis

Objective To systematically evaluate the prognostic value of circulating tumor cells (CTCs) in patients with non-small cell lung cancer (NSCLC).Methods We electronically searched CNIK, WanFang Data, CBM, VIP, PubMed, Web of Science, The Cochrane Library, and Embase database for literature regarding...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ming-Zhen LI, Shao-Hua HE, Ying-Hui JIN, Cheng CHEN, Si-Yu YAN, Yong-Bo WANG, Huan LIU, Zhi-Qing ZHOU, Han XIAO, Rui-Rui YANG, Li-Ming TAN
Format:	Article
Language:	zho
Published:	Editorial Office of New Medicine 2022-08-01
Series:	Yixue xinzhi zazhi
Subjects:	circulating tumor cell non-small cell lung cancer prognosis meta-analysis
Online Access:	https://yxxz.whuznhmedj.com/storage/attach/2208/dmyp4WKzxydm4aKhDBGKKRX4d4pHg7mKjs6mzQGa.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prognostic Value of the Number of Circulating Tumor Cells in Patients with Metastatic Non-Small Cell Lung Cancer
by: Arthur B. Volovetsky, et al.
Published: (2025-04-01)

Clinical Characteristics and Prognostic Value of Circulating Plasma Cells in Newly Diagnosed Multiple Myeloma Patients in China
by: Geng C, et al.
Published: (2025-05-01)

Immunophenotypic characteristics and prognostic value of peripheral blood circulating plasma cells in patients with newly diagnosed multiple myeloma
by: Chen Hong, et al.
Published: (2025-01-01)

PADI4 expression in baseline circulating tumour cells acts as a prognostic biomarker in oral squamous cell carcinoma
by: Anshika Chauhan, et al.
Published: (2025-03-01)

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer
by: Volga M Saini, et al.
Published: (2025-07-01)

Circulating Tumor Cell Detection for Therapeutic and Prognostic Roles in Breast Cancer
by: Saiying Ma, et al.
Published: (2025-06-01)

Circulating Tumor cells and multiple indicators combined to identify the risk of poorer prognosis in patients with resected non-small cell lung cancer
by: Jinghan Song, et al.
Published: (2024-12-01)

The potential of secretogranin V as a prognostic biomarker in non-small cell lung cancer
by: Weisong Zhang, et al.
Published: (2025-05-01)

Prognostic and clinicopathological value of fibrinogen-to-albumin ratio in non-small cell lung cancer: a meta-analysis
by: Ling Tong, et al.
Published: (2025-05-01)

Predictive role of circulating tumor DNA based molecular residual disease for long-term outcomes in non-small cell lung cancer patients: a meta-analysis
by: Siyuan Che, et al.
Published: (2025-06-01)

Detection of circulating tumor cells in peripheral blood of patients with tongue squamous cell carcinoma and its relationship with clinical features and prognosis: a retrospective study
by: Ningbo Geng, et al.
Published: (2024-11-01)

Combination of circulating tumor cells and 18F‐FDG PET/CT for precision diagnosis in patients with non‐small cell lung cancer
by: Momo Sun, et al.
Published: (2024-09-01)

Redefining cancer care: harnessing circulating tumor cells’ potential for improved diagnosis and prognosis
by: Divya Janjua, et al.
Published: (2025-07-01)

Development and validation of a 16-gene T-cell- related prognostic model in non-small cell lung cancer
by: Anbing Zhang, et al.
Published: (2025-04-01)

Prognostic value of the StAN score in elderly small cell lung cancer
by: Feride Yılmaz, et al.
Published: (2025-07-01)

The promises and perils of circulating tumor DNA for monitoring immunotherapy response in non-small cell lung cancer
by: Brandon Joseph Hebert, et al.
Published: (2024-11-01)

Overall survival in colon cancer patients with different levels of circulating tumor cells and feasibility of enhancing its prognostic value
by: O. I. Kit, et al.
Published: (2022-09-01)

Circulating tumor cells and clusters as liquid biomarkers for the diagnosis and prognosis of neuroblastoma
by: Huanli Xu, et al.
Published: (2025-07-01)

Impact of circulating lymphoma cells at diagnosis on outcomes in patients with newly diagnosed de novo diffuse large B-cell lymphoma
by: Sayan Mullick Chowdhury, et al.
Published: (2025-01-01)

Genomic signatures in plasma circulating tumor DNA reveal treatment response and prognostic insights in mantel cell lymphoma
by: Zhou Ouyang, et al.
Published: (2025-05-01)

Advances in biomarkers for immunotherapy in small-cell lung cancer
by: Hui Li, et al.
Published: (2024-12-01)

Clinical Significance of Circulating Tumor Cells in Gastric Cancer
by: Hye Kyung Jeon, et al.
Published: (2018-09-01)

Nanomaterial-based detection of circulating tumor cells and circulating cancer stem cells for cancer immunotherapy
by: Yeochan Yun, et al.
Published: (2024-12-01)

Connection between circulating inflammatory cytokines and non-small cell lung cancer: integrated Mendelian randomization and gene function analysis
by: Ke Niu, et al.
Published: (2025-06-01)

Development of a prognostic model for patients with extensive-stage small cell lung cancer undergoing immunotherapy and chemotherapy
by: Yunbin Gao, et al.
Published: (2025-03-01)

Mechanism and therapeutic targets of circulating immune cells in diabetic retinopathy
by: Bowen Zhao, et al.
Published: (2024-12-01)

Associations of blood RNA biomarkers and circulating tumour cells in patients with previously untreated metastatic colorectal cancer
by: Manuel Valladares-Ayerbes, et al.
Published: (2025-04-01)

Prognostic value of circulating HPV cell-free DNA in cervical cancer using liquid biopsy
by: Ashna Gupta, et al.
Published: (2025-04-01)

Reply to correspondence on “Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma”
by: Hyuk Soo Eun
Published: (2025-04-01)

Unsupervised Classification for Circulating Tumor Cells
by: Ling An, et al.
Published: (2025-01-01)

Identification of circulating tumor cells marker genes as prognostic signature in triple-negative breast cancer
by: Jia Hu, et al.
Published: (2025-05-01)

Prognostic significance of T cells and NK cells in osteosarcoma: a dual-center retrospective study
by: Kai Luo, et al.
Published: (2025-04-01)

Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer
by: Young-gon Kim, et al.
Published: (2024-10-01)

Effects of exercise on inflammation, circulating tumor cells, and circulating tumor DNA in colorectal cancer
by: Justin C. Brown, et al.
Published: (2025-12-01)

Ferroptosis-related lncRNAs as prognostic biomarkers in renal cell carcinoma: a systematic review and meta-analysis
by: Jia-Feng Lin, et al.
Published: (2025-05-01)

Natural killer cells: the immune frontline against circulating tumor cells
by: Doryan Masmoudi, et al.
Published: (2025-04-01)

Aberrant fragmentomic features of circulating cell-free mitochondrial DNA enable early detection and prognosis prediction of hepatocellular carcinoma
by: Yang Liu, et al.
Published: (2025-01-01)

Construction and validation of a cell-in-cell related prognostic signature for hepatocellular carcinoma
by: Hao Zhong, et al.
Published: (2025-08-01)

Circulating Tumour Cells and FOXP3 in Regulatory T-Cells as New Modalities in Cancer Diagnosis and Metastasis Location Prediction
by: Ikhwan Rinaldi
Published: (2024-01-01)

Multiple ctDNA- based biomarkers predict benefit from selective RET Inhibition in non-small cell lung cancer patients: exploratory analysis of a prospective study
by: Chang Lu, et al.
Published: (2025-07-01)